Bortezomib in Patients With Chronic Graft Versus Host Disease
Condition(s):Graft Versus Host DiseaseLast Updated:May 28, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Graft Versus Host DiseaseLast Updated:May 28, 2020Completed
Condition(s):Patients Awaiting a Living Kidney DonationLast Updated:September 29, 2016Unknown status
Condition(s):Multiple MyelomaLast Updated:January 8, 2018Completed
Condition(s):Multiple Myeloma; High-Risk CancerLast Updated:October 19, 2023Completed
Condition(s):Bronchiolitis ObliteransLast Updated:April 10, 2020Terminated
Condition(s):Bortezomib; Glomerulonephritis; MN; MPGN; FSGS; IgA NephropathyLast Updated:October 31, 2022Recruiting
Condition(s):Antibody-mediated RejectionLast Updated:July 18, 2023Recruiting
Condition(s):Lymphoma, FollicularLast Updated:April 1, 2014Terminated
Condition(s):Multiple MyelomaLast Updated:August 16, 2021Completed
Condition(s):Diffuse Large B Cell LymphomaLast Updated:October 23, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.